Hosted by: Diagnostic Solutions Laboratory
GLP-1 receptor agonists have transformed the treatment of obesity and type 2 diabetes, but their effects extend beyond weight loss. As more patients begin GLP‑1 therapy, practitioners are increasingly encountering GI symptoms, changes in bowel habits, digestive concerns, and questions about how these medications may influence gastrointestinal function and the gut microbiome.
In this webinar, Dr. Daniel Kalish of the Kalish Institute explores the connection between GLP‑1 medications and gut health through a functional medicine lens. He examines microbial balance, digestive function, and inflammation, along with bile acid metabolism and short-chain fatty acid production.
Dr. Kalish also discusses how GI‑MAP® and StoolOMX™ can be used together to provide complementary insights into gastrointestinal health and help practitioners investigate potential contributors to persistent digestive symptoms.
In this presentation, you’ll learn how to:
- Evaluate microbial balance, digestive function, and inflammation in patients taking GLP‑1 medications
- Explore bile acid metabolism and short-chain fatty acid production through metabolomic assessment
- Identify potential contributors to persistent GI symptoms and inform more personalized treatment strategies
- Use GI‑MAP and StoolOMX together to gain a more comprehensive view of the gastrointestinal ecosystem
About the Speaker
Dr. Daniel Kalish is dedicated to teaching doctors Functional Medicine philosophy and practices. He has trained over 1,000 practitioners worldwide in The Kalish Method, which solves patient challenges with a proven lab based approach through the Kalish Institute’s educational programs.
In May 2016, a research study published by two Mayo Clinic researchers confirmed the efficacy of The Kalish Method showing significant improvements in GI health, and quality of life in the study participants. The study was based on Dr. Kalish’s model of Functional Medicine based on 25 years of successful clinical results. Graduates of The Kalish Institute include practitioners ranging from Dr. Mercola’s medical staff, to Mayo Clinic and Cleveland Clinic physicians.
References to webinars are from our accredited laboratory network. Health care providers are encouraged to explore the original source material and apply their clinical expertise when interpreting this information.